Parkinson's Disease
Commentary
What’s new in brain health?
A new study shows that nonmedical treatment is effective in people with frequent episodic and chronic tension-type headache.
From the Journals
Can a ‘smart’ skin patch detect early neurodegenerative diseases?
The microneedle arrays detect neuroinflammatory biomarkers such as interleukin-6 in as little as 6 minutes.
Hitting a Nerve
The ongoing search for answers
We learn just as much, if not more, from a negative study as from a positive one.
Hitting a Nerve
Holding out hope for ambroxol
Literature Review
Antiepileptic drugs tied to increased Parkinson’s disease risk
A large case-control study found a considerably higher risk of developing Parkinson’s disease among patients who had taken AEDs in comparison with...
Literature Review
Prodromal Parkinson’s disease tied to significant functional impairment
Investigators suggest that prodromal Parkinson’s disease should be recognized as a distinct disease stage.
From the Journals
Annual U.S. Parkinson’s disease incidence 50% higher than earlier estimates
About 60,000-90,000 individuals older than 45 years are estimated to be diagnosed with Parkinson’s disease each year.
Literature Review
High drug costs exclude most neurology patients from cutting-edge treatment
“Our study of people with neurologic conditions found that fewer than 20% were being treated with new medications.”
Literature Review
Advancing health equity in neurology is essential to patient care
The final plenary session at the ANA annual conference offered insights into the underlying causes of health care disparities within neurology and...
From the Journals
Novel drug eases Parkinson’s-related constipation in early trial
The drug, ENT-01, targets abnormal clumps of alpha-synuclein that are a hallmark of Parkinson’s disease.
Conference Coverage
Research fails to justify post-COVID-19 wave of new-onset parkinsonism
While cases have been reported, current data do not yet justify the concept of a post–COVID-19 parkinsonism wave.